Literature DB >> 17196307

Impairment of spatial learning and memory in ELKL Motif Kinase1 (EMK1/MARK2) knockout mice.

Louis Segu1, Arnaud Pascaud, Pierre Costet, Michel Darmon, Marie-Christine Buhot.   

Abstract

The hyperphosphorylation of tau protein is one of the hallmarks of Alzheimer's disease (AD) and of the associated cognitive decline. EMK1 (MARK2) is a serine/threonine kinase which phosphorylates tau and MAP2. An involvement of this kinase in memory functions is not established. We used a behavioral approach to study the phenotype of EMK1-null mice (EMK1-KO) as a possible model of MAP2/tau altered phophorylation. Compared to wild type mice, EMK1-KO mice did not differ in non-cognitive aspects of behavior, such as locomotion in activity cages, or anxiety in the elevated plus maze. However, they exhibited lower performance in the first stage of acquisition of a hippocampal-dependent spatial learning, as assessed in a radial water maze, although, they acquired the task with repeated training. They were again found to be impaired on re-learning a new platform position. In addition, they exhibited poor long-term retention performance. These data underline the importance on both early memory processes and long-term retrieval, of the dynamic instability of microtubules generated by the phosphorylation of MAPs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196307     DOI: 10.1016/j.neurobiolaging.2006.10.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  A novel function of the cell polarity-regulating kinase PAR-1/MARK in dendritic spines.

Authors:  Kenji Hayashi; Atsushi Suzuki; Shigeo Ohno
Journal:  Bioarchitecture       Date:  2011-11-01

Review 2.  Polarity regulation in migrating neurons in the cortex.

Authors:  Orly Reiner; Tamar Sapir
Journal:  Mol Neurobiol       Date:  2009-03-28       Impact factor: 5.590

3.  Cellular polarity in aging: role of redox regulation and nutrition.

Authors:  Helena Soares; H Susana Marinho; Carla Real; Fernando Antunes
Journal:  Genes Nutr       Date:  2013-12-04       Impact factor: 5.523

4.  The polarity protein partitioning-defective 1 (PAR-1) regulates dendritic spine morphogenesis through phosphorylating postsynaptic density protein 95 (PSD-95).

Authors:  Qian Wu; Victoria L DiBona; Laura P Bernard; Huaye Zhang
Journal:  J Biol Chem       Date:  2012-07-17       Impact factor: 5.157

5.  Loss of Par-1a/MARK3/C-TAK1 kinase leads to reduced adiposity, resistance to hepatic steatosis, and defective gluconeogenesis.

Authors:  Jochen K Lennerz; Jonathan B Hurov; Lynn S White; Katherine T Lewandowski; Julie L Prior; G James Planer; Robert W Gereau; David Piwnica-Worms; Robert E Schmidt; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

6.  Inactivation of MARK4, an AMP-activated protein kinase (AMPK)-related kinase, leads to insulin hypersensitivity and resistance to diet-induced obesity.

Authors:  Chao Sun; Liang Tian; Jia Nie; Hai Zhang; Xiao Han; Yuguang Shi
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

Review 7.  Regulation of Cell Polarity by PAR-1/MARK Kinase.

Authors:  Youjun Wu; Erik E Griffin
Journal:  Curr Top Dev Biol       Date:  2016-12-05       Impact factor: 4.897

8.  Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2.

Authors:  Deidre Jansson; Andy Cheuk-Him Ng; Accalia Fu; Chantal Depatie; Mufida Al Azzabi; Robert A Screaton
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-14       Impact factor: 11.205

9.  Regulation of glucose homeostasis by KSR1 and MARK2.

Authors:  Paula J Klutho; Diane L Costanzo-Garvey; Robert E Lewis
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

10.  Immunotoxicity of β-Diketone Antibiotic Mixtures to Zebrafish (Danio rerio) by Transcriptome Analysis.

Authors:  Fanghui Li; Hui Wang; Jinfeng Liu; Jiebo Lin; Aibing Zeng; Weiming Ai; Xuedong Wang; Randy A Dahlgren; Huili Wang
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.